Emile Loria
chairmen
Board of Directors
OSE immuno therapetics
France
Biography
Dr. Emile Loria has more than 25 years of experience in the pharmaceutical and biotechnology sectors, occupying key positions, in particular with Ciba-Geigy and Sanofi Pharma. He was a researcher at the Cancer Institute in Villejuif and then at the Cancer and Immunogenetics Institute (INSERM-CNRS) founded by professor Georges Mathé. In 1986, he founded MS Medical Synergy, a drug management company. He then joined Biovector Therapeutics where he became Chairman and Chief Executive Officer. In 2001, Dr. Loria was appointed Chief Executive Officer of Epimmune and developed the epitopes technology, from which the Tedopi® epitopes stem. He ran this programme from initial research to the start of the Phase 2 clinical trial. In 2012, he purchased, via OPI sa (Geneva), all of the Memopi® assets, co-founded OSE Pharma and became Chairman of its Board. Dr. Loria is a doctor who specialises in oncology
Research Interest
Biovector therapeutics
